BioCentury
ARTICLE | Company News

Management tracks: BMS, Amicus, Armo, Noxxon

October 9, 2017 11:36 PM UTC

Bristol-Myers Squibb Co. (NYSE:BMY) named Saurabh Saha SVP and global head of translational medicine. He was a venture partner at Atlas Venture, as well as president and CEO at Delinia Inc., which Celgene Corp. (NASDAQ:CELG) acquired.

Rare disease company Amicus Therapeutics Inc. (NASDAQ:FOLD) named Michael Diem SVP of business and corporate development. He was SVP of corporate and business development at Aevi Genomic Medicine Inc. (NASDAQ:GNMX)...